Clorox Company (The) (NYSE:CLX) Given Consensus Rating of “Hold” by Analysts
Clorox Company (The) (NYSE:CLX) has received an average recommendation of “Hold” from the fifteen brokerages that are currently covering the company, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell recommendation, ten have assigned a hold recommendation and three have assigned a buy recommendation to the company. The average twelve-month price target among brokers that have covered the stock in the last year is $127.39.
Several research firms recently weighed in on CLX. Jefferies Group LLC reissued a “hold” rating and set a $137.00 price target (up from $136.00) on shares of Clorox Company (The) in a research report on Wednesday. Barclays PLC reissued an “equal weight” rating and set a $136.00 price target (down from $140.00) on shares of Clorox Company (The) in a research report on Friday, August 4th. BMO Capital Markets set a $150.00 price target on Clorox Company (The) and gave the company a “buy” rating in a research report on Thursday, August 3rd. Royal Bank Of Canada restated a “hold” rating and issued a $115.00 target price on shares of Clorox Company (The) in a research note on Wednesday, August 2nd. Finally, BidaskClub upgraded Clorox Company (The) from a “strong sell” rating to a “sell” rating in a research note on Monday, July 31st.
COPYRIGHT VIOLATION NOTICE: This report was originally published by Daily Political and is the sole property of of Daily Political. If you are reading this report on another website, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright legislation. The legal version of this report can be read at https://www.dailypolitical.com/2017/08/12/clorox-company-the-nyseclx-given-consensus-rating-of-hold-by-analysts.html.
Shares of Clorox Company (CLX) traded up 0.28% during mid-day trading on Friday, reaching $134.31. The company’s stock had a trading volume of 526,295 shares. The company has a market capitalization of $17.34 billion, a PE ratio of 25.18 and a beta of 0.40. The firm’s 50 day moving average is $133.58 and its 200-day moving average is $133.56. Clorox Company has a 52-week low of $111.24 and a 52-week high of $141.76.
Clorox Company (The) (NYSE:CLX) last posted its quarterly earnings results on Thursday, August 3rd. The company reported $1.53 earnings per share for the quarter, beating the consensus estimate of $1.49 by $0.04. The firm had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.65 billion. Clorox Company (The) had a return on equity of 190.67% and a net margin of 11.74%. Clorox Company (The)’s quarterly revenue was up 2.9% on a year-over-year basis. During the same period in the previous year, the firm earned $1.30 earnings per share. Analysts forecast that Clorox Company will post $5.67 EPS for the current year.
Hedge funds have recently added to or reduced their stakes in the company. BlackRock Inc. increased its stake in Clorox Company (The) by 1,402.2% in the first quarter. BlackRock Inc. now owns 10,390,206 shares of the company’s stock valued at $1,400,912,000 after buying an additional 9,698,542 shares during the period. Parnassus Investments CA bought a new stake in Clorox Company (The) during the first quarter valued at about $434,255,000. Vanguard Group Inc. increased its stake in Clorox Company (The) by 4.8% in the first quarter. Vanguard Group Inc. now owns 14,164,716 shares of the company’s stock valued at $1,909,829,000 after buying an additional 649,766 shares during the period. Ameriprise Financial Inc. increased its stake in Clorox Company (The) by 24.6% in the second quarter. Ameriprise Financial Inc. now owns 1,341,272 shares of the company’s stock valued at $178,433,000 after buying an additional 265,200 shares during the period. Finally, Renaissance Technologies LLC increased its stake in Clorox Company (The) by 24.5% in the second quarter. Renaissance Technologies LLC now owns 1,341,400 shares of the company’s stock valued at $178,728,000 after buying an additional 263,700 shares during the period. Institutional investors own 70.29% of the company’s stock.
About Clorox Company (The)
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.